NetworkNewsBreaks – Sigyn Therapeutics Inc. (SIG

NetworkNewsBreaks – Sigyn Therapeutics Inc. (SIGY) to Implement 1-for-40 Reverse Split

Sigyn Therapeutics (OTCQB: SIGY), a development-stage medical technology company, has announced a 1-for-40 reverse split of its common stock. The reverse split will go into effect tomorrow, Jan. 31, 2024. According to the company, its common stock will trade on a post-split basis at the beginning of the trading day on Jan. 31, under its existing trading symbol: SIGY. The announcement included pertinent stockholder information regarding the upcoming split. “The reverse stock split is intended to increase the market price per share of the company’s common stock to gain compliance with the minimum bid listing requirement of the NASDAQ Capital Market in connection with the company’s pending application for listing,” the company stated in the press release. “Proportionate adjustments will be made to the conversion and exercise prices of the company’s warrants, restricted stock unit awards, stock options and to the number of shares issued and issuable under the company’s equity incentive plans.”

NOTE TO INVESTORS: The latest news and updates relating to SIGY are available in the company’s newsroom at https://nnw.fm/SIGY

Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer